If your practice offers compounded semaglutide or tirzepatide, this is the most important question you can ask right now, and the answer changed underneath a lot of practices that have not noticed yet.
Here is the core of it. Compounded versions of GLP-1 drugs were widely available during the official FDA drug shortage, when compounding of otherwise-patented medications is permitted. But the FDA declared the tirzepatide shortage resolved in late 2024 and the semaglutide shortage resolved in early 2025. Once a drug leaves the shortage list, the legal basis for mass-compounding a copy of it largely disappears. Compounding a drug that is essentially a copy of a commercially available FDA-approved product is restricted under federal law.
So the honest 2026 answer is: for most practices, routine compounded semaglutide and tirzepatide are no longer on the safe legal footing they were in 2024. There remain narrow, legitimate paths, a documented clinical need a patient cannot meet with the commercial product, for example, but 'we compound because it is cheaper' is no longer a defensible position.
Enforcement has followed. The FDA has issued waves of warning letters to telehealth companies over claims about compounded GLP-1 products, and drug manufacturers have sued med spas, telehealth companies, and compounding pharmacies over compounded semaglutide. State attorneys general have opened investigations into direct-to-consumer weight-loss platforms on theories including unauthorized practice of medicine and deceptive trade practices. Separately, GLP-1 litigation overall has crossed thousands of filed lawsuits, many consolidated into federal multidistrict litigation.
There is an insurance dimension that catches practices off guard: many standard malpractice policies now exclude claims arising from compounded GLP-1 and off-label treatments. A weight-loss practice can believe it is insured and discover, at claim time, that its core service was excluded.
What a defensible weight-loss practice looks like now: proper patient evaluation and a good-faith exam, sourcing only from appropriately licensed pharmacies, honest marketing with no guaranteed-outcome claims, thorough documentation of medical necessity, and, crucially, insurance that explicitly covers what you prescribe.
In more than 25 years in this industry, we have never seen a service line shift legal footing as fast as GLP-1 has. The practices that stay safe are the ones treating compliance and coverage as moving targets, not settled questions.
Compounded GLP-1 is not automatically illegal, but the ground has shifted. Know where you actually stand, and make sure your coverage stands with you.
If you prescribe GLP-1, your coverage needs to explicitly say so, many standard policies now exclude it. We specialize in covering weight-loss and GLP-1 practices and have over 25 years in the industry. Check your eligibility and make sure your highest-revenue service is actually protected.
Check Your EligibilityIs compounded semaglutide still legal in 2026?
In most cases, no longer on the footing it had in 2024. After the FDA declared the semaglutide shortage resolved in early 2025, the legal basis for mass-compounding a copy of it largely disappeared. Narrow paths for documented individual clinical need may remain, but routine cost-based compounding is not defensible.
Do I need a DEA registration to prescribe GLP-1 medications?
No. GLP-1 drugs like semaglutide and tirzepatide are not controlled substances, so prescribing them does not require DEA registration. A practitioner does need appropriate state licensure and prescriptive authority.
Can my malpractice insurance exclude GLP-1 claims?
Yes. Many standard policies now exclude claims from compounded GLP-1 and off-label treatments. A weight-loss practice should confirm in writing that its policy covers what it prescribes, or obtain specialized coverage that does.
What makes a GLP-1 weight-loss practice defensible in 2026?
Proper patient evaluation and good-faith exams, sourcing from appropriately licensed pharmacies, honest marketing without guaranteed-outcome claims, documented medical necessity, and insurance that explicitly covers the service.
This article is provided by Wellness Medical Protection Group, LLC (“WMPG”) and is not an offer to purchase insurance or a guarantee of insurance coverage. It is intended to provide general educational information only. It is not legal advice, medical advice, or a recommendation regarding any specific clinical practice, and it should not be relied upon as a substitute for evaluating applicable legal requirements or the unique risks and insurance needs of a particular healthcare provider. Any insurance coverage is subject to the applicable policy’s terms, conditions, limitations, exclusions, and underwriting requirements, and the actual policy issued by the applicable carrier. Eligibility and coverage are determined only upon application and underwriting by the applicable carrier. Descriptions of coverage, exclusions, laws, and regulatory developments are general in nature, may not apply to your situation, and may change over time. WMPG does not guarantee the accuracy or completeness of the information provided in this article or other publications available on WMPG’s website. Providers should confirm current applicable requirements with their own counsel and the relevant licensing authorities before making coverage decisions or decisions about their operations. Last reviewed by counsel on August 26, 2026.
Running a weight-loss or GLP-1 program and unsure where you stand? Schedule a free consultation. We will review your exposure and make sure your coverage matches what you actually prescribe.
Schedule a Free Consultation